[ANTIMICROBIAL ACTION OF NOCARDIA VACCINII IMV B-7405 SURFACTANTS]

Area of Science:

• Microbiology
• Biotechnology
• Antimicrobial Agents

Background:

• Microbial surfactants are gaining attention for their diverse applications.
• Nocardia vaccinii IMV B-7405 is a source of potentially valuable bioactive compounds.

Purpose of the Study:

• To investigate the antimicrobial efficacy of surfactants produced by Nocardia vaccinii IMV B-7405.
• To evaluate these surfactants against a range of pathogenic and non-pathogenic microorganisms.

Main Methods:

• Surfactants were extracted from Nocardia vaccinii IMV B-7405 culture supernatant using a chloroform-methanol mixture.
• Antimicrobial activity was assessed using the Koch method and determining minimum inhibitory concentrations (MICs).

Main Results:

• Nocardia vaccinii IMV B-7405 surfactants demonstrated antimicrobial activity against bacteria (Proteus, Staphylococcus, Enterobacter), Candida yeast, and fungi (Aspergillus niger, Fusarium culmorum).
• MICs varied, with bacteria, yeast, and micromycetes showing ranges of 11.5-85.0, 11.5-22.5, and 165.0-325.0 µg/ml, respectively.
• Survival rates of Escherichia coli and Bacillus subtilis were significantly reduced (3-28%) after treatment.

Conclusions:

• The antimicrobial properties of N. vaccinii IMV B-7405 surfactants are concentration and exposure dependent.
• These microbial surfactants show comparable efficacy to known agents.
• Utilizing the culture liquid supernatant simplifies production and reduces costs, highlighting its potential as an antimicrobial agent.